Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

  1. Cuneo, A.
  2. Mato, A.R.
  3. Rigolin, G.M.
  4. Piciocchi, A.
  5. Gentile, M.
  6. Laurenti, L.
  7. Allan, J.N.
  8. Pagel, J.M.
  9. Brander, D.M.
  10. Hill, B.T.
  11. Winter, A.
  12. Lamanna, N.
  13. Tam, C.S.
  14. Jacobs, R.
  15. Lansigan, F.
  16. Barr, P.M.
  17. Shadman, M.
  18. Skarbnik, A.P.
  19. Pu, J.J.
  20. Sehgal, A.R.
  21. Schuster, S.J.
  22. Shah, N.N.
  23. Ujjani, C.S.
  24. Roeker, L.
  25. Orlandi, E.M.
  26. Billio, A.
  27. Trentin, L.
  28. Spacek, M.
  29. Marchetti, M.
  30. Tedeschi, A.
  31. Ilariucci, F.
  32. Gaidano, G.
  33. Doubek, M.
  34. Farina, L.
  35. Molica, S.
  36. Di Raimondo, F.
  37. Coscia, M.
  38. Mauro, F.R.
  39. de la Serna, J.
  40. Medina Perez, A.
  41. Ferrarini, I.
  42. Cimino, G.
  43. Cavallari, M.
  44. Cucci, R.
  45. Vignetti, M.
  46. Foà, R.
  47. Ghia, P.
  48. Erakutsi egile guztiak +
Aldizkaria:
Cancer Medicine

ISSN: 2045-7634

Argitalpen urtea: 2020

Alea: 9

Zenbakia: 22

Orrialdeak: 8468-8479

Mota: Artikulua

DOI: 10.1002/CAM4.3470 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus